Skip to main content
Premium Trial:

Request an Annual Quote

The Trial of Hwang Woo-Suk Continues

The three-year-long trial of South Korean stem cell scientist Hwang Woo-Suk continues as the prosecutors ask that Hwang be given a four-year prison term. Hwang is being tried for embezzlement and for violating bioethics laws. "He fabricated research outputs to show off his performances," a prosecutor said, according to the Korea Times. "He committed a grave crime in that his behavior dealt a blow to the Korean science circle and disappointed numerous citizens." The verdict is to be announced October 19th.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.